These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15338906)

  • 1. Cellular heterogeneity in cathepsin D distribution in equine articular cartilage.
    Hernandez-Vidal G; Jeffcott LB; Davies ME
    Equine Vet J; 1997 Jul; 29(4):267-73. PubMed ID: 15338906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolocalization of cathepsin B in equine dyschondroplastic articular cartilage.
    Hernández-Vidal G; Jeffcott LB; Davies ME
    Vet J; 1998 Nov; 156(3):193-201. PubMed ID: 9883087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential distribution of cathepsins B and L in articular cartilage during skeletal development in the horse.
    Gläser KE; Davies ME; Jeffcott LB
    Equine Vet J; 2003 Jan; 35(1):42-7. PubMed ID: 12553461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localisation and activity of cathepsins K and B in equine osteoclasts.
    Gray AW; Davies ME; Jeffcott LB
    Res Vet Sci; 2002 Apr; 72(2):95-103. PubMed ID: 12027589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do the matrix degrading enzymes cathepsins B and D increase following a high intensity exercise regime?
    Bowe EA; Murray RC; Jeffcott LB; Davies ME
    Osteoarthritis Cartilage; 2007 Mar; 15(3):343-9. PubMed ID: 17055751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine articular cartilage chondrocytes: opening the black box.
    Hall AC; Bush PG; Davidson ME; Kempson SA
    Equine Vet J; 2003 Jul; 35(5):425-8. PubMed ID: 12875317
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of transforming growth factor-beta 1 in normal and dyschondroplastic articular growth cartilage of the young horse.
    Henson FM; Schofield PN; Jeffcott LB
    Equine Vet J; 1997 Nov; 29(6):434-9. PubMed ID: 9413715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative importance of cysteine peptidases in osteoarthritis.
    Lang A; Hörler D; Baici A
    J Rheumatol; 2000 Aug; 27(8):1970-9. PubMed ID: 10955340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localisation of alkaline phosphatase in equine growth cartilage.
    Henson FM; Davies ME; Skepper JN; Jeffcott LB
    J Anat; 1995 Aug; 187 ( Pt 1)(Pt 1):151-9. PubMed ID: 7591976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage.
    Baici A; Lang A; Hörler D; Kissling R; Merlin C
    Ann Rheum Dis; 1995 Apr; 54(4):289-97. PubMed ID: 7763107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis.
    Konttinen YT; Mandelin J; Li TF; Salo J; Lassus J; Liljeström M; Hukkanen M; Takagi M; Virtanen I; Santavirta S
    Arthritis Rheum; 2002 Apr; 46(4):953-60. PubMed ID: 11953972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.
    Reesink HL; Sutton RM; Shurer CR; Peterson RP; Tan JS; Su J; Paszek MJ; Nixon AJ
    Stem Cell Res Ther; 2017 Nov; 8(1):243. PubMed ID: 29096716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes.
    Tung JT; Fenton JI; Arnold C; Alexander L; Yuzbasiyan-Gurkan V; Venta PJ; Peters TL; Orth MW; Richardson DW; Caron JP
    Can J Vet Res; 2002 Jan; 66(1):19-25. PubMed ID: 11858644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microscopic change in macroscopically normal equine cartilage from osteoarthritic joints.
    Weaver RE; Sharif M; Livingston LA; Andrews KL; Fuller CJ
    Connect Tissue Res; 2006; 47(2):92-101. PubMed ID: 16754515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium/calmodulin-dependent protein kinase II in human articular chondrocytes.
    Shimazaki A; Wright MO; Elliot K; Salter DM; Millward-Sadler SJ
    Biorheology; 2006; 43(3,4):223-33. PubMed ID: 16912396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuities in the endothelium of epiphyseal cartilage canals and relevance to joint disease in foals.
    Hellings IR; Ekman S; Hultenby K; Dolvik NI; Olstad K
    J Anat; 2016 Jan; 228(1):162-75. PubMed ID: 26471892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin D. Characteristics of immunoinhibition and the confirmation of a role in cartilage breakdown.
    Dingle JT; Barrett AJ; Weston PD
    Biochem J; 1971 Jun; 123(1):1-13. PubMed ID: 4256870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints.
    Clegg PD; Burke RM; Coughlan AR; Riggs CM; Carter SD
    Equine Vet J; 1997 Sep; 29(5):335-42. PubMed ID: 9306058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of cartilage oligomeric matrix protein (COMP) in equine carpal articular cartilage and its variation with exercise and cartilage deterioration.
    Murray RC; Smith RK; Henson FM; Goodship A
    Vet J; 2001 Sep; 162(2):121-8. PubMed ID: 11531396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage canals in equine articular/epiphyseal growth cartilage and a possible association with dyschondroplasia.
    Shingleton WD; Mackie EJ; Cawston TE; Jeffcott LB
    Equine Vet J; 1997 Sep; 29(5):360-4. PubMed ID: 9306061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.